Penumbra, Inc. (NYSE:PEN) Q1 2024 Earnings Call Transcript
Penumbra Is Maintained at Buy by Canaccord Genuity
Penumbra Is Maintained at Buy by Canaccord Genuity
Penumbra Price Target Cut to $272.00/Share From $284.00 by Canaccord Genuity
Penumbra Price Target Cut to $272.00/Share From $284.00 by Canaccord Genuity
Canaccord Genuity Maintains Buy on Penumbra, Lowers Price Target to $272
Canaccord Genuity analyst Jason Mills maintains Penumbra (NYSE:PEN) with a Buy and lowers the price target from $284 to $272.
Penumbra Is Maintained at Overweight by Piper Sandler
Penumbra Is Maintained at Overweight by Piper Sandler
Penumbra Price Target Cut to $260.00/Share From $290.00 by Piper Sandler
Penumbra Price Target Cut to $260.00/Share From $290.00 by Piper Sandler
Piper Sandler: Maintaining the Penumbra (PEN.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $290.00 to $260.00.
Piper Sandler: Maintaining the Penumbra (PEN.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $290.00 to $260.00.
Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand
Needham: Reiterates that Penumbra (PEN.US) holds the rating.
Needham: Reiterates that Penumbra (PEN.US) holds the rating.
Needham Reiterates Hold on Penumbra
Needham analyst Mike Matson reiterates Penumbra (NYSE:PEN) with a Hold.
Penumbra Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 — Needham Reiterates → Hold 04/03/2024 38.1% Piper Sandler $290 → $290 Reiterates Overweight →
Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating
Penumbra (PEN) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $235 to $300.
Buy Rating Affirmed for Penumbra on Strong Q1 Performance and Robust Growth Prospects
Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Repare Therapeutics (RPTX) and Penumbra (PEN)
Penumbra (PEN) Gets a Buy From Piper Sandler
RBC Capital Keeps Their Buy Rating on Penumbra (PEN)
Buy Rating Affirmed for Penumbra Amid Strong Q1 Revenue and Growth Prospects
Earnings Call Summary | Penumbra(PEN.US) Q1 2024 Earnings Conference
The following is a summary of the Penumbra, Inc. (PEN) Q1 2024 Earnings Call Transcript:Financial Performance:Penumbra's total revenues for Q1 were $278.7 million, marking a year-over-year increase of
Penumbra, Inc. (PEN) Q1 2024 Earnings Call Transcript
Penumbra, Inc. (PEN) Q1 2024 Earnings Call Transcript
Penumbra Inc (PEN) Surpasses Analyst Revenue Forecasts in Q1 2024
No Data